Package 0406-7018-03

Brand: buprenorphine hcl

Generic: buprenorphine hcl
NDC Package

Package Facts

Identity

Package NDC 0406-7018-03
Digits Only 0406701803
Product NDC 0406-7018
Product ID 0406-7018_12e82887-be89-46cd-a55a-46e9e2ef2cba
Description

30 TABLET in 1 BOTTLE (0406-7018-03)

Marketing

Marketing Status
Marketed Since 2026-01-19
Brand buprenorphine hcl
Generic buprenorphine hcl
Sample Package No

Linked Drug Pages (1)

Buprenorphine HCl ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBLINGUAL"], "spl_id": "12e82887-be89-46cd-a55a-46e9e2ef2cba", "openfda": {"upc": ["0304067018030", "0304067012038"], "unii": ["56W8MW3EN1"], "rxcui": ["351264", "351265"], "spl_set_id": ["b60d514d-a88a-4fa2-a5b0-30ac29e04973"], "manufacturer_name": ["SpecGx LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (0406-7018-03)", "package_ndc": "0406-7018-03", "marketing_start_date": "20260119"}], "brand_name": "Buprenorphine HCl", "product_id": "0406-7018_12e82887-be89-46cd-a55a-46e9e2ef2cba", "dosage_form": "TABLET", "pharm_class": ["Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "0406-7018", "dea_schedule": "CIII", "generic_name": "Buprenorphine HCl", "labeler_name": "SpecGx LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine HCl", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "8 mg/1"}], "application_number": "ANDA218473", "marketing_category": "ANDA", "marketing_start_date": "20260119", "listing_expiration_date": "20261231"}